Prescription-Only Domperidone: New MHRA Rules to Enhance Patient Safety
In a significant safety measure, the MHRA has mandated that Domperidone, a drug commonly used for treating nausea and vomiting, will require a prescription starting September 4th, 2014. This decision, stimulated by concerns over cardiovascular risks, underscores the importance of medical oversight in medication dispensing.